BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38217602)

  • 21. The Utility of Episodic Memory Cut-Off Scores for Inclusion in Clinical Trials for Early Symptomatic Alzheimer Disease.
    Randolph C
    Am J Geriatr Psychiatry; 2019 Dec; 27(12):1428-1432. PubMed ID: 31521488
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differences between episodic and semantic memory in predicting observation-based activities of daily living in mild cognitive impairment and Alzheimer's disease.
    Nakhla MZ; Banuelos D; Pagán C; Gavarrete Olvera A; Razani J
    Appl Neuropsychol Adult; 2022; 29(6):1499-1510. PubMed ID: 33689539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Episodic Memory and Learning Dysfunction Over an 18-Month Period in Preclinical and Prodromal Alzheimer's Disease.
    Baker JE; Lim YY; Jaeger J; Ames D; Lautenschlager NT; Robertson J; Pietrzak RH; Snyder PJ; Villemagne VL; Rowe CC; Masters CL; Maruff P
    J Alzheimers Dis; 2018; 65(3):977-988. PubMed ID: 30103330
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Semantic item-level metrics relate to future memory decline beyond existing cognitive tests in older adults without dementia.
    Vonk JMJ; Geerlings MI; Avila-Rieger JF; Qian CL; Schupf N; Mayeux R; Brickman AM; Manly JJ
    Psychol Aging; 2023 Aug; 38(5):443-454. PubMed ID: 37199965
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Validation study of "Santé-Cerveau", a digital tool for early cognitive changes identification.
    Lesoil C; Bombois S; Guinebretiere O; Houot M; Bahrami M; Levy M; Genthon R; Bozon F; Jean-Marie H; Epelbaum S; Foulon P; Villain N; Dubois B
    Alzheimers Res Ther; 2023 Apr; 15(1):70. PubMed ID: 37013590
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Similar autobiographical memory impairment in long-term secondary progressive multiple sclerosis and Alzheimer's disease.
    Müller S; Saur R; Greve B; Melms A; Hautzinger M; Fallgatter AJ; Leyhe T
    Mult Scler; 2013 Feb; 19(2):225-32. PubMed ID: 22685064
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Accelerated long-term forgetting in presymptomatic autosomal dominant Alzheimer's disease: a cross-sectional study.
    Weston PSJ; Nicholas JM; Henley SMD; Liang Y; Macpherson K; Donnachie E; Schott JM; Rossor MN; Crutch SJ; Butler CR; Zeman AZ; Fox NC
    Lancet Neurol; 2018 Feb; 17(2):123-132. PubMed ID: 29413314
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Validity of the French Prospective and Retrospective Memory Questionnaire (PRMQ) in healthy controls and in patients with no cognitive impairment, mild cognitive impairment and Alzheimer disease.
    Guerdoux-Ninot E; Martin S; Jailliard A; Brouillet D; Trouillet R
    J Clin Exp Neuropsychol; 2019 Nov; 41(9):888-904. PubMed ID: 31382847
    [No Abstract]   [Full Text] [Related]  

  • 29. Sex differences in cortisol and memory following acute social stress in amnestic mild cognitive impairment.
    Murphy KJ; Hodges TE; Sheppard PAS; Troyer AK; Hampson E; Galea LAM
    J Clin Exp Neuropsychol; 2020 Nov; 42(9):881-901. PubMed ID: 33023371
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Chinese version of story recall: a useful screening tool for mild cognitive impairment and Alzheimer's disease in the elderly.
    Shi J; Wei M; Tian J; Snowden J; Zhang X; Ni J; Li T; Jian W; Ma C; Tong Y; Liu J; Liu T; Wang P; Wang Y
    BMC Psychiatry; 2014 Mar; 14():71. PubMed ID: 24612772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acquisition and consolidation of verbal learning and episodic memory as predictors of the conversion from mild cognitive impairment to probable Alzheimer's disease.
    López-Pérez J; García-Herranz S; Díaz-Mardomingo MDC
    Neuropsychol Dev Cogn B Aging Neuropsychol Cogn; 2023 Jul; 30(4):638-653. PubMed ID: 35475773
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Voice biomarkers as indicators of cognitive changes in middle and later adulthood.
    Mahon E; Lachman ME
    Neurobiol Aging; 2022 Nov; 119():22-35. PubMed ID: 35964541
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Face-Name Associative Recognition Deficits in Subjective Cognitive Decline and Mild Cognitive Impairment.
    Polcher A; Frommann I; Koppara A; Wolfsgruber S; Jessen F; Wagner M
    J Alzheimers Dis; 2017; 56(3):1185-1196. PubMed ID: 28106560
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Neuropsychological impairment in the early Alzheimer's disease].
    Traykov L; Rigaud AS; Cesaro P; Boller F
    Encephale; 2007; 33(3 Pt 1):310-6. PubMed ID: 17675928
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alzheimer's disease risk factors as mediators of subjective memory impairment and objective memory decline: protocol for a construct-level replication analysis.
    Hill NL; Mogle J
    BMC Geriatr; 2018 Oct; 18(1):260. PubMed ID: 30373526
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differences in Subjective Cognitive Complaints Between Non-Demented Older Adults from a Memory Clinic and the Community.
    Markova H; Nikolai T; Mazancova AF; Cechova K; Sheardova K; Georgi H; Kopecek M; Laczó J; Hort J; Vyhnalek M
    J Alzheimers Dis; 2019; 70(1):61-73. PubMed ID: 31177209
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Subjective memory complaints in Chinese subjects with mild cognitive impairment and early Alzheimer's disease.
    Lam LC; Lui VW; Tam CW; Chiu HF
    Int J Geriatr Psychiatry; 2005 Sep; 20(9):876-82. PubMed ID: 16116581
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between Neuropsychological Performance and CSF Profile in Subjective Cognitive Decline: Towards the Diagnosis of Preclinical AD.
    Chipi E; Bellomo G; Salvadori N; Montanucci C; Gaetani L; Paolini Paoletti F; Parnetti L
    J Prev Alzheimers Dis; 2023; 10(3):523-529. PubMed ID: 37357293
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impairment of Episodic-Specific Autobiographical Memory in Individuals with Subjective Cognitive Decline and in Patients with Prodromal or Mild Alzheimer's Disease.
    Bruus AE; Waldemar G; Vogel A
    J Alzheimers Dis; 2021; 84(4):1485-1496. PubMed ID: 34690146
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of verbal episodic memory measures: consortium to establish a registry for Alzheimer's disease--Neuropsychological Assessment Battery (CERAD-NAB) versus California Verbal Learning Test (CVLT).
    Beck IR; Gagneux-Zurbriggen A; Berres M; Taylor KI; Monsch AU
    Arch Clin Neuropsychol; 2012 Aug; 27(5):510-9. PubMed ID: 22718104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.